We’re making vital connections

Antidote is on a mission to transform the way that sponsors and patients connect in order to accelerate medical research. To learn more, get in touch.


We're doing something that matters

At Antidote, we bring together talented people with pharmaceutical, technology, business, and public health backgrounds to achieve an important mission. Along the way, we manage to have some fun, too.

team-pic-Q2 2022

Thoughts from our team

“Since joining Antidote in 2021, I've really enjoyed my time here. The team is very welcoming, collaborative, and dedicated to our company values. Across all departments, I see how our team cares about producing high-quality work with the mindset of providing the best experience to clinical trial participants.”
“The people at Antidote are what makes this place such a joy to be part of. I love that we are non-hierarchical in our communication - you can reach out to anyone on a daily basis with a question or to set up a virtual coffee and catch up. Our executive team really cares about the people and that's evident in how we behave, how we collaborate, and how we celebrate our successes or pull together in difficult times. I am super proud to be an Antidote employee and the team we've built.”
“One of the reasons I joined Antidote was to be able to genuinely make a difference to people’s lives. The way in which everyone in Antidote comes together with such patient-centric focus whilst embodying our values is something very powerful. It’s great to be a part of such a dedicated team.”

Interested in Antidote’s company values and career opportunities?

Learn more


Laurent Schockmel

Laurent Schockmel

Bill Wesner

Bill Wesner

VP Business Development
Joanna Anderson

Joanna Anderson

VP People
Keith Lovell

Keith Lovell

Nicole Batiste

Nicole Batiste

VP Commercial Operations
Kulvinder Maingi

Kulvinder Maingi

Grace McElroy

Grace McElroy

VP Patient Experience & Partnerships
Sam Veeck

Sam Veeck

SVP Product

Our Board

David Currie

David Currie, Chairman of the Antidote Board, Codex Capital Partners LinkedIn

Kamran Adle

Kamran Adle, VC Investor, Octopus Ventures LinkedIn

Kara Dennis

Kara Dennis, Head of Healthcare, Unqork LinkedIn

Keith Lovell

Keith Lovell, CFO, Antidote LinkedIn

Jordan Mayo

Jordan Mayo, CEO, Profile Pensions LinkedIn

Franck Noiret

Franck Noiret, Managing Director - Venture Team, LBO France LinkedIn

Laurent Schockmel

Laurent Schockmel, CEO, Antidote LinkedIn

Prem Tumkosit

Prem Tumkosit, Managing Director, Merck GHI LinkedIn

Sébastien Woynar

Sébastien Woynar, Investment Director & Board Member, LBO France LinkedIn

Connect with Antidote

We’d love to hear from you